[go: up one dir, main page]

IL236381A0 - Pharmaceutical compositions for treatment of cancer - Google Patents

Pharmaceutical compositions for treatment of cancer

Info

Publication number
IL236381A0
IL236381A0 IL236381A IL23638114A IL236381A0 IL 236381 A0 IL236381 A0 IL 236381A0 IL 236381 A IL236381 A IL 236381A IL 23638114 A IL23638114 A IL 23638114A IL 236381 A0 IL236381 A0 IL 236381A0
Authority
IL
Israel
Prior art keywords
cancer
treatment
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL236381A
Other languages
Hebrew (he)
Original Assignee
Nurit Livnah
Yoram Sela
Pninit Litman
Itschak Lamensdorf
Pharma Two B Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nurit Livnah, Yoram Sela, Pninit Litman, Itschak Lamensdorf, Pharma Two B Ltd filed Critical Nurit Livnah
Priority to IL236381A priority Critical patent/IL236381A0/en
Publication of IL236381A0 publication Critical patent/IL236381A0/en

Links

IL236381A 2014-12-21 2014-12-21 Pharmaceutical compositions for treatment of cancer IL236381A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL236381A IL236381A0 (en) 2014-12-21 2014-12-21 Pharmaceutical compositions for treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL236381A IL236381A0 (en) 2014-12-21 2014-12-21 Pharmaceutical compositions for treatment of cancer

Publications (1)

Publication Number Publication Date
IL236381A0 true IL236381A0 (en) 2015-04-30

Family

ID=54347958

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236381A IL236381A0 (en) 2014-12-21 2014-12-21 Pharmaceutical compositions for treatment of cancer

Country Status (1)

Country Link
IL (1) IL236381A0 (en)

Similar Documents

Publication Publication Date Title
HUS2500001I1 (en) Antibody compositions for tumor treatment
IL290823A (en) Pharmaceutical compositions for combination therapy
IL268316B (en) Pharmaceutical compositions for combination therapy
IL258955B1 (en) Compositions and methods for treatment of cancer
ZA201703585B (en) Combination immunotherapy approach for treatment of cancer
IL285077A (en) Compounds for treatment of cancer
EP3148532A4 (en) Pharmaceutical combination for the treatment of cancer
LT3122358T (en) Combinations of fgfr- and cmet-inhibitors for the treatment of cancer
IL249231A0 (en) Pharmaceutical combinations for treating cancer
SG11201607130RA (en) Combination method for treatment of cancer
ZA201606075B (en) Pharmaceutical compositions of sitagliptin
IL261278A (en) Pharmaceutical compositions for the treatment of cancer
GB201408297D0 (en) Treatment of cancer
PT3142641T (en) Formulations for treatment of hyperthyroidism
IL255167A0 (en) Compositions for the treatment of cancer
PL3164110T3 (en) Pharmaceutical compositions for the treatment of psoriasis
GB201417456D0 (en) Treatment of cancer
IL236381A0 (en) Pharmaceutical compositions for treatment of cancer
ZA201704589B (en) Compounds for the treatment of cancer
GB201409362D0 (en) Treatment of cancer
GB201405449D0 (en) Treatment of cancer
GB201405075D0 (en) Treatment of cancer
GB201512723D0 (en) Treatment of cancer
HK1236134A1 (en) Pharmaceutical combination for the treatment of cancer
GB201507928D0 (en) Treatment of cancer